Yibin Kang is a Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University and an Associate Director of Rutgers Cancer Institute of New Jersey. He is also a founder member of the Ludwig Institute for Cancer Research Princeton Branch. Dr. Kang graduated with a bachelor’s degree from Fudan University in Shanghai in 1995. After completing his graduate study at Duke in 2000 and postdoctoral training at the Memorial Sloan-Kettering Cancer Center, he joined the faculty of Princeton University as an Assistant Professor of Molecular Biology in 2004. He was promoted to Associate Professor with tenure in 2010 and to Endowed Chair Full Professor in 2012. Dr. Kang has served as the President of the Metastasis Research Society (2016-2018) and Chair of the American Association for Cancer Research (AACR) Tumor Microenvironment Working Group (2018-2019). Dr. Kang’s research focuses on the molecular mechanisms of breast cancer metastasis. He has published over 170 research articles in leading journals including Science, Cancer Cell, and Nature Medicine. Dr. Kang's outstanding achievements have been recognized by many prestigious awards, including the 2011 Vicek Prize for Creative Promise in Biomedical Sciences, and the American Association for Cancer Research (AACR) Award for Outstanding Achievements in Cancer Research (2012), and the AACR Outstanding Investigator Award in Breast Cancer Research (2014). Dr. Kang was elected as a Fellow of American Association for the Advancement of Science (AAAS) and a Komen Scholar in 2016 and an American Cancer Society Research Professor in 2019.
Research Interests: Cancer, stem cell, drug development